Welcome and Introductions

18:00 – 18:05

Ulrich Keilholz, GE

Immunotherapy From Science to Clinical Practice – Potential Role of Checkpoint Inhibitors

18:05 – 18:20

Ulrich Keilholz, GE

Optimizing Therapy for Advanced Melanoma: The Immunotherapy Paradigm

18:20 – 18:40

Sanjiv Agarwala, USA

Immunotherapy in Head and Neck Cancer: Results and Ongoing Clinical Trials

18:40 – 19:00

Tanguy Seiwert, USA

Immunotherapy in Genitourinary Cancers: Results and Ongoing Clinical Trials

19:00 – 19:20

Dean Bajorin, USA

Management of Patients Receiving Checkpoint Inhibitors

19:20 – 19:35

Sanjiv Agarwala, USA

Discussion and Q&A

19:35 – 19:55

Sanjiv Agarwala, USA; Tanguy Seiwert, USA; Dean Bajorin, USA

Closing Remarks

19:55 – 20:00

Ulrich Keilholz, GE